Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 321

1.

Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.

Wuttke M, Wong CS, Wühl E, Epting D, Luo L, Hoppmann A, Doyon A, Li Y; CKDGen Consortium, Sözeri B, Thurn D, Helmstädter M, Huber TB, Blydt-Hansen TD, Kramer-Zucker A, Mehls O, Melk A, Querfeld U, Furth SL, Warady BA, Schaefer F, Köttgen A.

Nephrol Dial Transplant. 2016 Feb;31(2):262-9. doi: 10.1093/ndt/gfv342. Epub 2015 Sep 28.

2.

Face-to-face Sun Protection Training and Text Messages Improve Sun Protection Behaviour in Adolescent Organ Transplant Recipients: HIPPOlino Feasibility Study.

Sachse MM, Böttcher S, Pape L, Wagner G, Mehls O, Klaus G, Laschewski G, Barz M, Jahn I, Zeeb H.

Acta Derm Venereol. 2016 Mar;96(3):341-5. doi: 10.2340/00015555-2234.

3.

Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.

Mehls O, Lindberg A, Haffner D, Schaefer F, Wühl E; German KIGS Board; ESCAPE Trial Group.

Pediatr Nephrol. 2015 Dec;30(12):2145-51. doi: 10.1007/s00467-015-3157-8. Epub 2015 Jul 22.

PMID:
26198275
4.

Pathogens causing urinary tract infections in infants: a European overview by the ESCAPE study group.

Alberici I, Bayazit AK, Drozdz D, Emre S, Fischbach M, Harambat J, Jankauskiene A, Litwin M, Mir S, Morello W, Peco-Antic A, Sallay P, Sever L, Simonetti GD, Szczesniak P, Teixeira A, Vidal E, Wuehl E, Mehls O, Weber LT, Schaefer F, Montini G; ESCAPE Study Group; PREDICT Trial.

Eur J Pediatr. 2015 Jun;174(6):783-90. doi: 10.1007/s00431-014-2459-3. Epub 2014 Nov 28. Review.

PMID:
25428232
5.

Height gain in Ullrich-Turner syndrome after early and late growth hormone treatment start: results from a large retrospective German study and potential basis for an individualized treatment approach.

Bettendorf M, Inta IM, Doerr HG, Hauffa BP, Mehls O, Ranke MB.

Horm Res Paediatr. 2013;80(5):356-62. doi: 10.1159/000356045. Epub 2013 Nov 6.

PMID:
24217296
6.

Growth hormone treatment after renal transplantation: a promising but underused chance to improve growth.

Mehls O, Fine RN.

Pediatr Nephrol. 2013 Jan;28(1):1-4. doi: 10.1007/s00467-012-2293-7. Epub 2012 Sep 5.

PMID:
22948320
7.

Missed OPPORTUNITY: growth hormone therapy in adults with CKD.

Mehls O, Schaefer F.

Nephrol Dial Transplant. 2011 Dec;26(12):3835-7. doi: 10.1093/ndt/gfr623. No abstract available.

PMID:
22121238
8.

Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.

Reinehr T, Bechtold-Dalla Pozza S, Bettendorf M, Doerr HG, Gohlke B, Hauffa BP, Kaspers S, Land C, Mehls O, Schwab KO, Stahnke N, Ranke MB; German KIGS Study Board.

Exp Clin Endocrinol Diabetes. 2011 Oct;119(9):544-8. doi: 10.1055/s-0031-1285913. Epub 2011 Oct 17.

PMID:
22006181
9.

Mineral and bone disorders in children with chronic kidney disease.

Schmitt CP, Mehls O.

Nat Rev Nephrol. 2011 Sep 27;7(11):624-34. doi: 10.1038/nrneph.2011.139. Review.

PMID:
21947120
10.

Dosing of glucocorticosteroids in nephrotic syndrome.

Mehls O, Hoyer PF.

Pediatr Nephrol. 2011 Dec;26(12):2095-8. doi: 10.1007/s00467-011-1993-8. Epub 2011 Sep 9. No abstract available.

PMID:
21904778
11.

Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children.

Dörr HG, Bettendorf M, Hauffa BP, Mehls O, Rohrer T, Stahnke N, Pfäffle R, Ranke MB; German KIGS Group.

Clin Endocrinol (Oxf). 2011 Nov;75(5):656-60. doi: 10.1111/j.1365-2265.2011.04104.x.

PMID:
21623854
12.

Response to GH in chronic renal failure. Prediction and treatment strategies.

Mehls O.

Minerva Pediatr. 2010 Jun;62(3):267-72. No abstract available.

PMID:
20467379
13.

Growth and body composition in very young SGA children.

Argente J, Mehls O, Barrios V.

Pediatr Nephrol. 2010 Apr;25(4):679-85. doi: 10.1007/s00467-009-1432-2. Epub 2010 Jan 27. Review.

PMID:
20108001
14.

Predicting the response to growth hormone treatment in short children with chronic kidney disease.

Mehls O, Lindberg A, Nissel R, Haffner D, Hokken-Koelega A, Ranke MB.

J Clin Endocrinol Metab. 2010 Feb;95(2):686-92. doi: 10.1210/jc.2009-1114. Epub 2009 Dec 11.

PMID:
20008024
15.

Strict blood-pressure control and progression of renal failure in children.

ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.

N Engl J Med. 2009 Oct 22;361(17):1639-50. doi: 10.1056/NEJMoa0902066.

16.

Is the response to growth hormone in short children born small for gestational age dependent on genetic or maternal factors?

Mehls O, Lindberg A, Bettendorf M, Doerr HG, Hauffa BP, Kaspers S, Rohrer T, Stahnke N, Ranke MB; German KIGS Board.

Horm Res. 2009;72(2):106-13. doi: 10.1159/000232163. Epub 2009 Aug 18.

PMID:
19690428
17.

Functional analysis of BMP4 mutations identified in pediatric CAKUT patients.

Tabatabaeifar M, Schlingmann KP, Litwin M, Emre S, Bakkaloglu A, Mehls O, Antignac C, Schaefer F, Weber S; ESCAPE Trial Group.

Pediatr Nephrol. 2009 Dec;24(12):2361-8. doi: 10.1007/s00467-009-1287-6. Epub 2009 Aug 14.

PMID:
19685083
18.

Limitations of dual x-ray absorptiometry in children with chronic kidney disease.

Weber LT, Mehls O.

Pediatr Nephrol. 2010 Jan;25(1):3-5. doi: 10.1007/s00467-009-1248-0. Epub 2009 Jul 15.

PMID:
19603191
19.

Differential regulation of RGS-2 by constant and oscillating PTH concentrations.

Hömme M, Schaefer F, Mehls O, Schmitt CP.

Calcif Tissue Int. 2009 Apr;84(4):305-12. doi: 10.1007/s00223-009-9222-1. Epub 2009 Feb 20.

PMID:
19225708
20.

Happy holidays from the editors of Pediatric Nephrology.

Mehls O, Baum M.

Pediatr Nephrol. 2009 Jan;24(1):1. doi: 10.1007/s00467-008-1065-x. No abstract available.

PMID:
19023601
21.

Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit?

Port RE, Mehls O.

Pediatr Nephrol. 2009 Mar;24(3):435-7. doi: 10.1007/s00467-008-0955-2. Epub 2008 Aug 12. Erratum in: Pediatr Nephrol. 2009 Aug;24(8):1603.

PMID:
18696118
22.

Growth hormone treatment in short children with chronic kidney disease.

Mehls O, Wühl E, Tönshoff B, Schaefer F, Nissel R, Haffner D.

Acta Paediatr. 2008 Sep;97(9):1159-64. doi: 10.1111/j.1651-2227.2008.00845.x. Review.

PMID:
18624988
23.

Salt restriction in kidney disease--a missed therapeutic opportunity?

Ritz E, Mehls O.

Pediatr Nephrol. 2009 Jan;24(1):9-17. doi: 10.1007/s00467-008-0856-4. Epub 2008 Jun 6. Review.

24.

Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease.

Litwin M, Wühl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F.

Nephrol Dial Transplant. 2008 Aug;23(8):2552-7. doi: 10.1093/ndt/gfn083. Epub 2008 Mar 14.

PMID:
18344239
25.

SIX2 and BMP4 mutations associate with anomalous kidney development.

Weber S, Taylor JC, Winyard P, Baker KF, Sullivan-Brown J, Schild R, Knüppel T, Zurowska AM, Caldas-Alfonso A, Litwin M, Emre S, Ghiggeri GM, Bakkaloglu A, Mehls O, Antignac C, Network E, Schaefer F, Burdine RD.

J Am Soc Nephrol. 2008 May;19(5):891-903. doi: 10.1681/ASN.2006111282. Epub 2008 Feb 27.

26.

Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease.

Nissel R, Lindberg A, Mehls O, Haffner D; Pfizer International Growth Database (KIGS) International Board.

J Clin Endocrinol Metab. 2008 Apr;93(4):1359-65. doi: 10.1210/jc.2007-2302. Epub 2008 Jan 15.

PMID:
18198222
27.

Clinical course and NPHS2 analysis in patients with late steroid-resistant nephrotic syndrome.

Schwaderer P, Knüppel T, Konrad M, Mehls O, Schärer K, Schaefer F, Weber S.

Pediatr Nephrol. 2008 Feb;23(2):251-6. Epub 2007 Nov 14.

PMID:
18000687
28.

Central laboratory reassessment of IGF-I, IGF-binding protein-3, and GH serum concentrations measured at local treatment centers in growth-impaired children: implications for the agreement between outpatient screening and the results of somatotropic axis functional testing.

Hauffa BP, Lehmann N, Bettendorf M, Mehls O, Dörr HG, Stahnke N, Steinkamp H, Said E, Ranke MB; German KIGS Board/Medical Outcome Study Group.

Eur J Endocrinol. 2007 Nov;157(5):597-603.

PMID:
17984239
29.

Urinary excretion of endothelin-1 (ET-1), transforming growth factor- beta1 (TGF- beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial.

Grenda R, Wühl E, Litwin M, Janas R, Sladowska J, Arbeiter K, Berg U, Caldas-Afonso A, Fischbach M, Mehls O, Sallay P, Schaefer F; ESCAPE Trial group.

Nephrol Dial Transplant. 2007 Dec;22(12):3487-94. Epub 2007 Sep 26.

PMID:
17901069
30.

Reduced systolic myocardial function in children with chronic renal insufficiency.

Chinali M, de Simone G, Matteucci MC, Picca S, Mastrostefano A, Anarat A, Caliskan S, Jeck N, Neuhaus TJ, Peco-Antic A, Peruzzi L, Testa S, Mehls O, Wühl E, Schaefer F; ESCAPE Trial Group.

J Am Soc Nephrol. 2007 Feb;18(2):593-8. Epub 2007 Jan 10.

31.

Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study.

Weber S, Moriniere V, Knüppel T, Charbit M, Dusek J, Ghiggeri GM, Jankauskiené A, Mir S, Montini G, Peco-Antic A, Wühl E, Zurowska AM, Mehls O, Antignac C, Schaefer F, Salomon R.

J Am Soc Nephrol. 2006 Oct;17(10):2864-70. Epub 2006 Sep 13.

32.

Related and unrelated living donor transplantation.

Mehls O, Baum M.

Pediatr Nephrol. 2006 Oct;21(10):1351. No abstract available.

PMID:
16823573
33.

Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment.

Bettendorf M, Doerr HG, Hauffa BP, Lindberg A, Mehls O, Partsch CJ, Schwarz HP, Stahnke N, Ranke MB.

J Pediatr Endocrinol Metab. 2006 Feb;19(2):149-54.

PMID:
16562588
34.

Left ventricular geometry in children with mild to moderate chronic renal insufficiency.

Matteucci MC, Wühl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F; ESCAPE Trial Group.

J Am Soc Nephrol. 2006 Jan;17(1):218-26. Epub 2005 Nov 9.

35.

Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents.

Jourdan C, Wühl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Tröger J, Schaefer F.

J Hypertens. 2005 Sep;23(9):1707-15.

PMID:
16093916
36.

Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease.

Rosenkranz J, Reichwald-Klugger E, Oh J, Turzer M, Mehls O, Schaefer F.

Pediatr Nephrol. 2005 Sep;20(9):1288-94. Epub 2005 Jun 8.

PMID:
15942781
37.

Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation.

Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Tröger J, Mehls O, Schaefer F.

J Am Soc Nephrol. 2005 May;16(5):1494-500. Epub 2005 Mar 16.

38.

Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001.

Doerr HG, Bettendorf M, Hauffa BP, Mehls O, Partsch CJ, Said E, Sander S, Schwarz HP, Stahnke N, Steinkamp H, Ranke MB.

Hum Reprod. 2005 May;20(5):1418-21. Epub 2005 Feb 3.

PMID:
15695313
39.

Ultradian but not circadian blood pressure rhythms correlate with renal dysfunction in children with chronic renal failure.

Wühl E, Hadtstein C, Mehls O, Schaefer F; ESCAPE Trial Group.

J Am Soc Nephrol. 2005 Mar;16(3):746-54. Epub 2005 Jan 12.

40.

Longitudinal analysis of T-helper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy.

Melk A, Daniel V, Mehls O, Opelz G, Tönshoff B.

Transplantation. 2004 Dec 27;78(12):1792-801.

PMID:
15614153
41.

Pediatric renal transplantation and the dysfunctional bladder.

Adams J, Mehls O, Wiesel M.

Transpl Int. 2004 Nov;17(10):596-602. Epub 2004 Oct 29.

42.

Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells.

Hömme M, Schmitt CP, Mehls O, Schaefer F.

J Am Soc Nephrol. 2004 Nov;15(11):2844-50.

43.

Analysis of the functional muscle-bone unit of the forearm in pediatric renal transplant recipients.

Rüth EM, Weber LT, Schoenau E, Wunsch R, Seibel MJ, Feneberg R, Mehls O, Tönshoff B.

Kidney Int. 2004 Oct;66(4):1694-706.

44.

Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.

Höcker B, John U, Plank C, Wühl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tönshoff B.

Transplantation. 2004 Jul 27;78(2):228-34.

PMID:
15280683
45.

Reversible end-stage renal disease in an adolescent patient with methylmalonic aciduria.

Schmitt CP, Mehls O, Trefz FK, Hörster F, Weber TL, Kölker S.

Pediatr Nephrol. 2004 Oct;19(10):1182-4. Epub 2004 Jul 16. No abstract available.

PMID:
15258847
46.

Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.

Weber LT, Armstrong VW, Shipkova M, Feneberg R, Wiesel M, Mehls O, Zimmerhackl LB, Oellerich M, Tönshoff B; Members of the German Study Group on Pediatric Renal Transplantion.

Ther Drug Monit. 2004 Aug;26(4):415-24.

PMID:
15257072
47.

Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.

Wühl E, Mehls O, Schaefer F; ESCAPE Trial Group.

Kidney Int. 2004 Aug;66(2):768-76.

48.

Long-term results of paediatric kidney transplantation at the University of Heidelberg: a 35 year single-centre experience.

Mehrabi A, Kashfi A, Tönshoff B, Feneberg R, Mehls O, Schemmer P, Kraus T, Wiesel M, Büchler MW, Schmidt J.

Nephrol Dial Transplant. 2004 Jul;19 Suppl 4:iv69-74.

PMID:
15240854
49.

Rat growth plate chondrocytes express low levels of 25-hydroxy-1alpha-hydroxylase.

Hügel U, Weber L, Reichrath J, Mehls O, Klaus G.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):143-7.

PMID:
15225762
50.

Supplemental Content

Support Center